ForSight Robotics

ForSight Robotics

Intraocular robotic platform for eye surgery

Overview

ForSight Robotics develops a robotic platform for eye surgery. It combines a hybrid intraocular robot with surgical tools to help ophthalmologists perform procedures with higher precision and efficiency. The system is used in medical institutions such as eye clinics and hospitals and is designed to assist surgeons during procedures by stabilizing motion, enabling delicate micromovements, and improving control through a robotic interface. The company plans to sell or lease the platform and provide training, software updates, and ongoing support to customers, aiming to create long-term service relationships. The product is not yet FDA-cleared and is pursuing regulatory approval before commercialization.

About ForSight Robotics

Simplify's Rating
Why ForSight Robotics is rated
C+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Robotics & Automation

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$190M

Headquarters

Kfar Yona, Israel

Founded

2020

Get referred to ForSight Robotics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The 26-patient first-in-human study stayed 100% robotically completed without manual conversion.
  • Series B financing raised $125 million in 2025, extending runway through pivotal trials.
  • Primary completion is targeted for February 2027, keeping a near-term catalyst visible.

What critics are saying

  • JASPER remains unapproved for commercial use, forcing ForSight into years of regulatory dependency.
  • February 2027 trial completion still leaves FDA review, manufacturing scale-up, and reimbursement unresolved.
  • If cataract surgeons reject telemanipulation, JASPER becomes an expensive demo and capital sink.

What makes ForSight Robotics unique

  • JASPER performed the world's first fully robot-assisted cataract surgery on April 7, 2026.
  • Dr. Fred Moll's board seat validates ForSight's surgical robotics credibility and distribution access.
  • ISO 13485:2016 certification and 26-patient study show disciplined medical-device execution.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$190M

Above

Industry Average

Funded Over

3 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$65M
Substack
$100M
ClickUp
$125M
ForSight Robotics

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

4%

2 year growth

2%
Business Wire
Apr 7th, 2026
ForSight Robotics completes world's first fully robot-assisted cataract surgery

ForSight Robotics has completed the world's first fully robot-assisted cataract surgery in a human patient using its JASPER Platform. The procedure was performed by Dr Alexey Rapoport at the Asian Eye Institute in Manila, marking the first time a cataract surgery has been completed entirely robotically without general anaesthesia. Unlike previous partial robotic procedures, the JASPER Platform assists surgeons through every step of cataract surgery, providing advanced imaging, precision and motion scaling whilst reducing surgeon fatigue. The system is designed to address a global shortage of trained surgeons and improve access to care. An estimated 600 million people worldwide need cataract surgery, yet only 30 million procedures are performed annually. Following its Series B funding in 2025, ForSight Robotics will advance toward clinical validation and regulatory submissions.

Assembly Magazine
Jul 3rd, 2025
Startup Raises $125M to Bring Robot-Assisted Cataract Surgery to Market

ForSight Robotics, an Israeli startup, is developing the world's first robotic system for cataract and eye surgery.

Tech Funding News
Jun 27th, 2025
ForSight Robotics raises $125M to bring first-ever eye surgery robot to clinical trials

ForSight Robotics, the Israeli startup pioneering robotic systems for eye surgery, has secured $125 million in a Series B round led by Eclipse, with participation from an undisclosed strategic investor, the Adani Group, Reiya Ventures, Dr. Fred Moll, and other existing backers.

Lucidity Insights
Jun 25th, 2025
ForSight Robotics Gets $125M Series B to Transform Ophthalmic Surgery

ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced today it completed a $125M Series B round, led by Eclipse.

Business Wire
Jun 25th, 2025
ForSight Robotics Secures $125M in Series B Funding, Addressing Global Surgeon Shortage and Exploding Demand for Ophthalmic Surgery

ForSight Robotics secures $125M Series B funding, led by Eclipse, to tackle global vision crisis and perform robotic cataract surgery clinical trials.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for ForSight Robotics right now.

Find jobs on Simplify and start your career today

We update ForSight Robotics's jobs every few hours, so check again soon! Browse all jobs →